APO Research
Talk to an analyst

APO RESEARCH · REPORT

Molecular Cloning Solutions

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Molecular Cloning Solutions Market Analysis and Forecast 2026-2032

30 January 2026191 pages

Choose your research edition.

Industry ResearchMolecular Cloning Solutions Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Molecular Cloning Solutions Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Molecular Cloning Solutions Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Molecular Cloning Solutions Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Molecular Cloning Solutions Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Molecular Cloning Solutions market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Molecular Cloning Solutions is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Molecular Cloning Solutions is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Molecular Cloning Solutions is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Molecular Cloning Solutions is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Molecular Cloning Solutions include VectorBuilder, BioServUK, GenScript, urofins Genomics, Innoprot, Genewiz, Bio-Fab Research, OriGene and Prospec-Tany Technogene, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Molecular Cloning Solutions, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Molecular Cloning Solutions, also provides the revenue of main regions and countries. Of the upcoming market potential for Molecular Cloning Solutions, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Molecular Cloning Solutions revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Molecular Cloning Solutions market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Molecular Cloning Solutions revenue, projected growth trends, production technology, application and end-user industry.

Molecular Cloning Solutions Segment by Company

VectorBuilder

BioServUK

GenScript

urofins Genomics

Innoprot

Genewiz

Bio-Fab Research

OriGene

Prospec-Tany Technogene

Addgene

Protein Ark

Protomnis

RD-Biotech

Charles River

Molecular Cloning Solutions Segment by Type

Restriction Enzyme Cloning

Primer Amplification Cloning

Gene Library Cloning

Gene Mutation Cloning

Genomic Cloning

Molecular Cloning Solutions Segment by Application

Laboratory

Research Institute

Others

Molecular Cloning Solutions Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Molecular Cloning Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Molecular Cloning Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Molecular Cloning Solutions.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Molecular Cloning Solutions in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Molecular Cloning Solutions company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Molecular Cloning Solutions revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Molecular Cloning Solutions Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Restriction Enzyme Cloning Major Player Table 3. Primer Amplification Cloning Major Player Table 4. Gene Library Cloning Major Player Table 5. Gene Mutation Cloning Major Player Table 6. Genomic Cloning Major Player Table 7. Global Molecular Cloning Solutions Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Laboratory Major Player Table 9. Research Institute Major Player Table 10. Others Major Player Table 11. Molecular Cloning Solutions Industry Trends Table 12. Molecular Cloning Solutions Industry Drivers Table 13. Molecular Cloning Solutions Industry Opportunities and Challenges Table 14. Molecular Cloning Solutions Industry Restraints Table 15. Global Molecular Cloning Solutions Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Molecular Cloning Solutions Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Molecular Cloning Solutions Market Share by Region (2021-2026) Table 18. Global Molecular Cloning Solutions Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Molecular Cloning Solutions Market Share by Region (2027-2032) Table 20. Global Molecular Cloning Solutions Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Molecular Cloning Solutions Revenue Market Share by Players (2021-2026) Table 22. Global Molecular Cloning Solutions Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Molecular Cloning Solutions Key Players Headquarters & Area Served Table 24. Global Molecular Cloning Solutions Players, Product Type & Application Table 25. Global Molecular Cloning Solutions Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Molecular Cloning Solutions by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Molecular Cloning Solutions Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Molecular Cloning Solutions Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Molecular Cloning Solutions Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Molecular Cloning Solutions Revenue Market Share by Type (2021-2026) Table 32. Global Molecular Cloning Solutions Revenue Market Share by Type (2027-2032) Table 33. Global Molecular Cloning Solutions Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Molecular Cloning Solutions Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Molecular Cloning Solutions Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Molecular Cloning Solutions Revenue Market Share by Application (2021-2026) Table 37. Global Molecular Cloning Solutions Revenue Market Share by Application (2027-2032) Table 38. VectorBuilder Company Information Table 39. VectorBuilder Business Overview Table 40. VectorBuilder Molecular Cloning Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. VectorBuilder Molecular Cloning Solutions Product Portfolio Table 42. VectorBuilder Recent Development Table 43. BioServUK Company Information Table 44. BioServUK Business Overview Table 45. BioServUK Molecular Cloning Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. BioServUK Molecular Cloning Solutions Product Portfolio Table 47. BioServUK Recent Development Table 48. GenScript Company Information Table 49. GenScript Business Overview Table 50. GenScript Molecular Cloning Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. GenScript Molecular Cloning Solutions Product Portfolio Table 52. GenScript Recent Development Table 53. urofins Genomics Company Information Table 54. urofins Genomics Business Overview Table 55. urofins Genomics Molecular Cloning Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. urofins Genomics Molecular Cloning Solutions Product Portfolio Table 57. urofins Genomics Recent Development Table 58. Innoprot Company Information Table 59. Innoprot Business Overview Table 60. Innoprot Molecular Cloning Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Innoprot Molecular Cloning Solutions Product Portfolio Table 62. Innoprot Recent Development Table 63. Genewiz Company Information Table 64. Genewiz Business Overview Table 65. Genewiz Molecular Cloning Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Genewiz Molecular Cloning Solutions Product Portfolio Table 67. Genewiz Recent Development Table 68. Bio-Fab Research Company Information Table 69. Bio-Fab Research Business Overview Table 70. Bio-Fab Research Molecular Cloning Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Bio-Fab Research Molecular Cloning Solutions Product Portfolio Table 72. Bio-Fab Research Recent Development Table 73. OriGene Company Information Table 74. OriGene Business Overview Table 75. OriGene Molecular Cloning Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. OriGene Molecular Cloning Solutions Product Portfolio Table 77. OriGene Recent Development Table 78. Prospec-Tany Technogene Company Information Table 79. Prospec-Tany Technogene Business Overview Table 80. Prospec-Tany Technogene Molecular Cloning Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Prospec-Tany Technogene Molecular Cloning Solutions Product Portfolio Table 82. Prospec-Tany Technogene Recent Development Table 83. Addgene Company Information Table 84. Addgene Business Overview Table 85. Addgene Molecular Cloning Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Addgene Molecular Cloning Solutions Product Portfolio Table 87. Addgene Recent Development Table 88. Protein Ark Company Information Table 89. Protein Ark Business Overview Table 90. Protein Ark Molecular Cloning Solutions Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Protein Ark Molecular Cloning Solutions Product Portfolio Table 92. Protein Ark Recent Development Table 93. Protomnis Company Information Table 94. Protomnis Business Overview Table 95. Protomnis Molecular Cloning Solutions Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Protomnis Molecular Cloning Solutions Product Portfolio Table 97. Protomnis Recent Development Table 98. RD-Biotech Company Information Table 99. RD-Biotech Business Overview Table 100. RD-Biotech Molecular Cloning Solutions Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. RD-Biotech Molecular Cloning Solutions Product Portfolio Table 102. RD-Biotech Recent Development Table 103. Charles River Company Information Table 104. Charles River Business Overview Table 105. Charles River Molecular Cloning Solutions Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Charles River Molecular Cloning Solutions Product Portfolio Table 107. Charles River Recent Development Table 108. North America Molecular Cloning Solutions Revenue by Type (2021-2026) & (US$ Million) Table 109. North America Molecular Cloning Solutions Revenue by Type (2027-2032) & (US$ Million) Table 110. North America Molecular Cloning Solutions Revenue by Application (2021-2026) & (US$ Million) Table 111. North America Molecular Cloning Solutions Revenue by Application (2027-2032) & (US$ Million) Table 112. North America Molecular Cloning Solutions Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. North America Molecular Cloning Solutions Revenue by Country (2021-2026) & (US$ Million) Table 114. North America Molecular Cloning Solutions Revenue by Country (US$ Million) & (2027-2032) Table 115. Europe Molecular Cloning Solutions Revenue by Type (2021-2026) & (US$ Million) Table 116. Europe Molecular Cloning Solutions Revenue by Type (2027-2032) & (US$ Million) Table 117. Europe Molecular Cloning Solutions Revenue by Application (2021-2026) & (US$ Million) Table 118. Europe Molecular Cloning Solutions Revenue by Application (2027-2032) & (US$ Million) Table 119. Europe Molecular Cloning Solutions Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. Europe Molecular Cloning Solutions Revenue by Country (2021-2026) & (US$ Million) Table 121. Europe Molecular Cloning Solutions Revenue by Country (US$ Million) & (2027-2032) Table 122. China Molecular Cloning Solutions Revenue by Type (2021-2026) & (US$ Million) Table 123. China Molecular Cloning Solutions Revenue by Type (2027-2032) & (US$ Million) Table 124. China Molecular Cloning Solutions Revenue by Application (2021-2026) & (US$ Million) Table 125. China Molecular Cloning Solutions Revenue by Application (2027-2032) & (US$ Million) Table 126. Asia Molecular Cloning Solutions Revenue by Type (2021-2026) & (US$ Million) Table 127. Asia Molecular Cloning Solutions Revenue by Type (2027-2032) & (US$ Million) Table 128. Asia Molecular Cloning Solutions Revenue by Application (2021-2026) & (US$ Million) Table 129. Asia Molecular Cloning Solutions Revenue by Application (2027-2032) & (US$ Million) Table 130. Asia Molecular Cloning Solutions Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 131. Asia Molecular Cloning Solutions Revenue by Region (US$ Million) & (2021-2026) Table 132. Asia Molecular Cloning Solutions Revenue by Region (US$ Million) & (2027-2032) Table 133. SAMEA Molecular Cloning Solutions Revenue by Type (2021-2026) & (US$ Million) Table 134. SAMEA Molecular Cloning Solutions Revenue by Type (2027-2032) & (US$ Million) Table 135. SAMEA Molecular Cloning Solutions Revenue by Application (2021-2026) & (US$ Million) Table 136. SAMEA Molecular Cloning Solutions Revenue by Application (2027-2032) & (US$ Million) Table 137. SAMEA Molecular Cloning Solutions Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. SAMEA Molecular Cloning Solutions Revenue by Country (2021-2026) & (US$ Million) Table 139. SAMEA Molecular Cloning Solutions Revenue by Country (US$ Million) & (2027-2032) Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Molecular Cloning Solutions Image Figure 2. Global Molecular Cloning Solutions Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Molecular Cloning Solutions Market Size Share 2021 VS 2025 VS 2032 Figure 4. Restriction Enzyme Cloning Image Figure 5. Primer Amplification Cloning Image Figure 6. Gene Library Cloning Image Figure 7. Gene Mutation Cloning Image Figure 8. Genomic Cloning Image Figure 9. Global Molecular Cloning Solutions Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Molecular Cloning Solutions Market Size Share 2021 VS 2025 VS 2032 Figure 11. Laboratory Image Figure 12. Research Institute Image Figure 13. Others Image Figure 14. Global Molecular Cloning Solutions Market Size (US$ Million) & (2021-2032) Figure 15. Global Molecular Cloning Solutions Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Molecular Cloning Solutions Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Molecular Cloning Solutions Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Molecular Cloning Solutions Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Molecular Cloning Solutions Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Molecular Cloning Solutions Revenue Market Share by Type (2021-2032) Figure 22. Global Molecular Cloning Solutions Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Molecular Cloning Solutions Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Molecular Cloning Solutions Revenue Market Share by Application (2021-2032) Figure 25. North America Molecular Cloning Solutions Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Molecular Cloning Solutions Revenue Share by Type (2021-2032) Figure 27. North America Molecular Cloning Solutions Revenue Share by Application (2021-2032) Figure 28. North America Molecular Cloning Solutions Revenue Share by Country (2021-2032) Figure 29. United States Molecular Cloning Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Molecular Cloning Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Molecular Cloning Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Molecular Cloning Solutions Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Molecular Cloning Solutions Revenue Share by Type (2021-2032) Figure 34. Europe Molecular Cloning Solutions Revenue Share by Application (2021-2032) Figure 35. Europe Molecular Cloning Solutions Revenue Share by Country (2021-2032) Figure 36. Germany Molecular Cloning Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Molecular Cloning Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Molecular Cloning Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Molecular Cloning Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Molecular Cloning Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Molecular Cloning Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Molecular Cloning Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Molecular Cloning Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Molecular Cloning Solutions Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Molecular Cloning Solutions Revenue Share by Type (2021-2032) Figure 46. China Molecular Cloning Solutions Revenue Share by Application (2021-2032) Figure 47. Asia Molecular Cloning Solutions Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Molecular Cloning Solutions Revenue Share by Type (2021-2032) Figure 49. Asia Molecular Cloning Solutions Revenue Share by Application (2021-2032) Figure 50. Asia Molecular Cloning Solutions Revenue Share by Region (2021-2032) Figure 51. Japan Molecular Cloning Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Molecular Cloning Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Molecular Cloning Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Molecular Cloning Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Molecular Cloning Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Molecular Cloning Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Molecular Cloning Solutions Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Molecular Cloning Solutions Revenue Share by Type (2021-2032) Figure 59. SAMEA Molecular Cloning Solutions Revenue Share by Application (2021-2032) Figure 60. SAMEA Molecular Cloning Solutions Revenue Share by Country (2021-2032) Figure 61. Brazil Molecular Cloning Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Molecular Cloning Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Molecular Cloning Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Molecular Cloning Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Molecular Cloning Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Molecular Cloning Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Molecular Cloning Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Molecular Cloning Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Molecular Cloning Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Molecular Cloning Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Molecular Cloning Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Restriction Enzyme Cloning
  • Primer Amplification Cloning
  • Gene Library Cloning
  • Gene Mutation Cloning
  • Genomic Cloning
Applications
  • Laboratory
  • Research Institute
  • Others
Companies covered
  • VectorBuilder
  • BioServUK
  • GenScript
  • urofins Genomics
  • Innoprot
  • Genewiz
  • Bio-Fab Research
  • OriGene
  • Prospec-Tany Technogene
  • Addgene
  • Protein Ark
  • Protomnis
  • RD-Biotech
  • Charles River

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Molecular Cloning Solutions Market by Type
  3. 1.2.1 Global Molecular Cloning Solutions Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Restriction Enzyme Cloning
  5. 1.2.3 Primer Amplification Cloning
  6. 1.2.4 Gene Library Cloning
  7. 1.2.5 Gene Mutation Cloning
  8. 1.2.6 Genomic Cloning
  9. 1.3 Molecular Cloning Solutions Market by Application
  10. 1.3.1 Global Molecular Cloning Solutions Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Laboratory
  12. 1.3.3 Research Institute
  13. 1.3.4 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Molecular Cloning Solutions Market Dynamics
  1. 2.1 Molecular Cloning Solutions Industry Trends
  2. 2.2 Molecular Cloning Solutions Industry Drivers
  3. 2.3 Molecular Cloning Solutions Industry Opportunities and Challenges
  4. 2.4 Molecular Cloning Solutions Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Molecular Cloning Solutions Market Perspective (2021-2032)
  2. 3.2 Global Molecular Cloning Solutions Growth Trends by Region
  3. 3.2.1 Global Molecular Cloning Solutions Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Molecular Cloning Solutions Market Size by Region (2021-2026)
  5. 3.2.3 Global Molecular Cloning Solutions Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Molecular Cloning Solutions Revenue by Players
  2. 4.1.1 Global Molecular Cloning Solutions Revenue by Players (2021-2026)
  3. 4.1.2 Global Molecular Cloning Solutions Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Molecular Cloning Solutions Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Molecular Cloning Solutions Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Molecular Cloning Solutions Key Players Headquarters & Area Served
  7. 4.4 Global Molecular Cloning Solutions Players, Product Type & Application
  8. 4.5 Global Molecular Cloning Solutions Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Molecular Cloning Solutions Market CR5 and HHI
  11. 4.6.3 2025 Molecular Cloning Solutions Tier 1, Tier 2, and Tier 3
5 Molecular Cloning Solutions Market Size by Type
  1. 5.1 Global Molecular Cloning Solutions Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Molecular Cloning Solutions Revenue by Type (2021-2032)
  3. 5.3 Global Molecular Cloning Solutions Revenue Market Share by Type (2021-2032)
6 Molecular Cloning Solutions Market Size by Application
  1. 6.1 Global Molecular Cloning Solutions Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Molecular Cloning Solutions Revenue by Application (2021-2032)
  3. 6.3 Global Molecular Cloning Solutions Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 VectorBuilder
  2. 7.1.1 VectorBuilder Company Information
  3. 7.1.2 VectorBuilder Business Overview
  4. 7.1.3 VectorBuilder Molecular Cloning Solutions Revenue and Gross Margin (2021-2026)
  5. 7.1.4 VectorBuilder Molecular Cloning Solutions Product Portfolio
  6. 7.1.5 VectorBuilder Recent Developments
  7. 7.2 BioServUK
  8. 7.2.1 BioServUK Company Information
  9. 7.2.2 BioServUK Business Overview
  10. 7.2.3 BioServUK Molecular Cloning Solutions Revenue and Gross Margin (2021-2026)
  11. 7.2.4 BioServUK Molecular Cloning Solutions Product Portfolio
  12. 7.2.5 BioServUK Recent Developments
  13. 7.3 GenScript
  14. 7.3.1 GenScript Company Information
  15. 7.3.2 GenScript Business Overview
  16. 7.3.3 GenScript Molecular Cloning Solutions Revenue and Gross Margin (2021-2026)
  17. 7.3.4 GenScript Molecular Cloning Solutions Product Portfolio
  18. 7.3.5 GenScript Recent Developments
  19. 7.4 urofins Genomics
  20. 7.4.1 urofins Genomics Company Information
  21. 7.4.2 urofins Genomics Business Overview
  22. 7.4.3 urofins Genomics Molecular Cloning Solutions Revenue and Gross Margin (2021-2026)
  23. 7.4.4 urofins Genomics Molecular Cloning Solutions Product Portfolio
  24. 7.4.5 urofins Genomics Recent Developments
  25. 7.5 Innoprot
  26. 7.5.1 Innoprot Company Information
  27. 7.5.2 Innoprot Business Overview
  28. 7.5.3 Innoprot Molecular Cloning Solutions Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Innoprot Molecular Cloning Solutions Product Portfolio
  30. 7.5.5 Innoprot Recent Developments
  31. 7.6 Genewiz
  32. 7.6.1 Genewiz Company Information
  33. 7.6.2 Genewiz Business Overview
  34. 7.6.3 Genewiz Molecular Cloning Solutions Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Genewiz Molecular Cloning Solutions Product Portfolio
  36. 7.6.5 Genewiz Recent Developments
  37. 7.7 Bio-Fab Research
  38. 7.7.1 Bio-Fab Research Company Information
  39. 7.7.2 Bio-Fab Research Business Overview
  40. 7.7.3 Bio-Fab Research Molecular Cloning Solutions Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Bio-Fab Research Molecular Cloning Solutions Product Portfolio
  42. 7.7.5 Bio-Fab Research Recent Developments
  43. 7.8 OriGene
  44. 7.8.1 OriGene Company Information
  45. 7.8.2 OriGene Business Overview
  46. 7.8.3 OriGene Molecular Cloning Solutions Revenue and Gross Margin (2021-2026)
  47. 7.8.4 OriGene Molecular Cloning Solutions Product Portfolio
  48. 7.8.5 OriGene Recent Developments
  49. 7.9 Prospec-Tany Technogene
  50. 7.9.1 Prospec-Tany Technogene Company Information
  51. 7.9.2 Prospec-Tany Technogene Business Overview
  52. 7.9.3 Prospec-Tany Technogene Molecular Cloning Solutions Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Prospec-Tany Technogene Molecular Cloning Solutions Product Portfolio
  54. 7.9.5 Prospec-Tany Technogene Recent Developments
  55. 7.10 Addgene
  56. 7.10.1 Addgene Company Information
  57. 7.10.2 Addgene Business Overview
  58. 7.10.3 Addgene Molecular Cloning Solutions Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Addgene Molecular Cloning Solutions Product Portfolio
  60. 7.10.5 Addgene Recent Developments
  61. 7.11 Protein Ark
  62. 7.11.1 Protein Ark Company Information
  63. 7.11.2 Protein Ark Business Overview
  64. 7.11.3 Protein Ark Molecular Cloning Solutions Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Protein Ark Molecular Cloning Solutions Product Portfolio
  66. 7.11.5 Protein Ark Recent Developments
  67. 7.12 Protomnis
  68. 7.12.1 Protomnis Company Information
  69. 7.12.2 Protomnis Business Overview
  70. 7.12.3 Protomnis Molecular Cloning Solutions Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Protomnis Molecular Cloning Solutions Product Portfolio
  72. 7.12.5 Protomnis Recent Developments
  73. 7.13 RD-Biotech
  74. 7.13.1 RD-Biotech Company Information
  75. 7.13.2 RD-Biotech Business Overview
  76. 7.13.3 RD-Biotech Molecular Cloning Solutions Revenue and Gross Margin (2021-2026)
  77. 7.13.4 RD-Biotech Molecular Cloning Solutions Product Portfolio
  78. 7.13.5 RD-Biotech Recent Developments
  79. 7.14 Charles River
  80. 7.14.1 Charles River Company Information
  81. 7.14.2 Charles River Business Overview
  82. 7.14.3 Charles River Molecular Cloning Solutions Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Charles River Molecular Cloning Solutions Product Portfolio
  84. 7.14.5 Charles River Recent Developments
8 North America
  1. 8.1 North America Molecular Cloning Solutions Revenue (2021-2032)
  2. 8.2 North America Molecular Cloning Solutions Revenue by Type (2021-2032)
  3. 8.2.1 North America Molecular Cloning Solutions Revenue by Type (2021-2026)
  4. 8.2.2 North America Molecular Cloning Solutions Revenue by Type (2027-2032)
  5. 8.3 North America Molecular Cloning Solutions Revenue Share by Type (2021-2032)
  6. 8.4 North America Molecular Cloning Solutions Revenue by Application (2021-2032)
  7. 8.4.1 North America Molecular Cloning Solutions Revenue by Application (2021-2026)
  8. 8.4.2 North America Molecular Cloning Solutions Revenue by Application (2027-2032)
  9. 8.5 North America Molecular Cloning Solutions Revenue Share by Application (2021-2032)
  10. 8.6 North America Molecular Cloning Solutions Revenue by Country
  11. 8.6.1 North America Molecular Cloning Solutions Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Molecular Cloning Solutions Revenue by Country (2021-2026)
  13. 8.6.3 North America Molecular Cloning Solutions Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Molecular Cloning Solutions Revenue (2021-2032)
  2. 9.2 Europe Molecular Cloning Solutions Revenue by Type (2021-2032)
  3. 9.2.1 Europe Molecular Cloning Solutions Revenue by Type (2021-2026)
  4. 9.2.2 Europe Molecular Cloning Solutions Revenue by Type (2027-2032)
  5. 9.3 Europe Molecular Cloning Solutions Revenue Share by Type (2021-2032)
  6. 9.4 Europe Molecular Cloning Solutions Revenue by Application (2021-2032)
  7. 9.4.1 Europe Molecular Cloning Solutions Revenue by Application (2021-2026)
  8. 9.4.2 Europe Molecular Cloning Solutions Revenue by Application (2027-2032)
  9. 9.5 Europe Molecular Cloning Solutions Revenue Share by Application (2021-2032)
  10. 9.6 Europe Molecular Cloning Solutions Revenue by Country
  11. 9.6.1 Europe Molecular Cloning Solutions Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Molecular Cloning Solutions Revenue by Country (2021-2026)
  13. 9.6.3 Europe Molecular Cloning Solutions Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Molecular Cloning Solutions Revenue (2021-2032)
  2. 10.2 China Molecular Cloning Solutions Revenue by Type (2021-2032)
  3. 10.2.1 China Molecular Cloning Solutions Revenue by Type (2021-2026)
  4. 10.2.2 China Molecular Cloning Solutions Revenue by Type (2027-2032)
  5. 10.3 China Molecular Cloning Solutions Revenue Share by Type (2021-2032)
  6. 10.4 China Molecular Cloning Solutions Revenue by Application (2021-2032)
  7. 10.4.1 China Molecular Cloning Solutions Revenue by Application (2021-2026)
  8. 10.4.2 China Molecular Cloning Solutions Revenue by Application (2027-2032)
  9. 10.5 China Molecular Cloning Solutions Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Molecular Cloning Solutions Revenue (2021-2032)
  2. 11.2 Asia Molecular Cloning Solutions Revenue by Type (2021-2032)
  3. 11.2.1 Asia Molecular Cloning Solutions Revenue by Type (2021-2026)
  4. 11.2.2 Asia Molecular Cloning Solutions Revenue by Type (2027-2032)
  5. 11.3 Asia Molecular Cloning Solutions Revenue Share by Type (2021-2032)
  6. 11.4 Asia Molecular Cloning Solutions Revenue by Application (2021-2032)
  7. 11.4.1 Asia Molecular Cloning Solutions Revenue by Application (2021-2026)
  8. 11.4.2 Asia Molecular Cloning Solutions Revenue by Application (2027-2032)
  9. 11.5 Asia Molecular Cloning Solutions Revenue Share by Application (2021-2032)
  10. 11.6 Asia Molecular Cloning Solutions Revenue by Country
  11. 11.6.1 Asia Molecular Cloning Solutions Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Molecular Cloning Solutions Revenue by Country (2021-2026)
  13. 11.6.3 Asia Molecular Cloning Solutions Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Molecular Cloning Solutions Revenue (2021-2032)
  2. 12.2 SAMEA Molecular Cloning Solutions Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Molecular Cloning Solutions Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Molecular Cloning Solutions Revenue by Type (2027-2032)
  5. 12.3 SAMEA Molecular Cloning Solutions Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Molecular Cloning Solutions Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Molecular Cloning Solutions Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Molecular Cloning Solutions Revenue by Application (2027-2032)
  9. 12.5 SAMEA Molecular Cloning Solutions Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Molecular Cloning Solutions Revenue by Country
  11. 12.6.1 SAMEA Molecular Cloning Solutions Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Molecular Cloning Solutions Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Molecular Cloning Solutions Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst